Screening of cervical cancer – theoretical background

Česká verzia

Authors: J. Ondruš ¹; V. Dvořák ²
Authors place of work: Centrum gynekologické onkologické prevence Havířov, vedoucí MUDr. J. Ondruš, M. I. A. C. ¹; Centrum ambulantní gynekologie a primární péče, vedoucí MUDr. V. Dvořák ²
Published in the journal: Ceska Gynekol 2010; 75(1): 62-64

Summary

Objective:
To show the basic rules for creation of creening programme in case of cervical cancer’s screening.

Design:
Review article.

Setting:
Centrum of gyneco-oncology prevention, Havířov.

Methods:
Study of the current literature.

Conclusion:
Screening programme should be set up economic possibilities of state. It must cover all risk group. It should have high specificity and sensitivity. This test should be connected with diagnostic methods and appropriate therapy.

Key word:
cervical cancer, screening, specificity, sensitivity.

Zdroje

1. Anttila, A., Ronco, G., Arbyn, M., et al. Cervical Cancer Screening Programmes and Policies in 18 European countries. Br J Cancer, 2004, 9, p. 935-941.

2. DeMay, RM. The art and science of cytopathology i: exfoliative cytology. Chicago: ASCP Press, 1996, p. 462.

3. European Guidelines for Quality Assurance in Cervical Cancer Screening, 2nd ed. IARC. European Communities, 2008, p. 291.

4. IARC Screening Group – Chapter: Anatomical and Pathological Basis of Visual Inspection with Acetic Acid (VIA) and with Lugol@s iodine (VILI ). Dostupné z www:<http://screening. iarc.fr/viavilichap l.php>

5. Leinmüller, R. Der PAP-Test stö3t an seine Grenz. Deutsches Ärzteblatt 95, 1998, 10, A-848.

6. Manos, MM., Kinney, WK., Hurley, LB., et al. Identifying women with cervical neoplasia: using human papillomavirus dna testing for equivocal Papanicolaou results. JAMA, 1999, 281, 17, p. 1605-1610.

7. Miller, AB. Cervical Cancer Screening Programmes: Managerial guidelines. Geneva: WHO, 1992.

8. Monsenego, J., Bosch, FX., et al. Mini Review UICG: Cervical cancer control, priorities and new directions. Int J Cancer, 2004, 108, p. 329-333.

9. Parkin, DM., Whelan, SL., Ferlay, J., et al. Cancer incidence in five continents. Lyon: IARC Scientific Publications, 1997, p. 143.

10. Petry, KU. HPV Screening zur Früherkennung des Zervixkarzinoms. Gynäkologe, 2003, 36, p. 289-296.

11. Sedlis, A. The pitfalls of cervical cancer screening. Gynecol Obstet, 1991, 18, p. 103-114.

12. Schiffman, M. Clinical opinion: evidence – based screening and management guidelines address the realistic concerns of practicing clinicians and pathologists. J Lower Genital Tract Dis, 2004, 2, p. 150-154.

13. Solomon, D., Papillo, JL., Davey, DD. Statement on HPV DNA Test Utilization. Acta Cytol, 2009, 53, 3, p. 249-250.

14. World Health Organization. Screening for cancer of the uterine cervix. IARC. Geneva: WHO, 1986.